참고문헌 (50)

1. Gut Arnold 66 683 2017 10.1136/gutjnl-2015-310912 Global patterns and trends in colorectal cancer incidence and mortality 

   상세보기

2. J Natl Cancer Inst Siegel 109 1 2017 10.1093/jnci/djw322 Colorectal cancer incidence patterns in the United States, 1974-2013 

   상세보기

3. World J Gastrointest Pathophysiol Kanwar 3 1 2012 10.4291/wjgp.v3.i1.1 Regulation of colon cancer recurrence and development of therapeutic strategies 

   상세보기

4. Cell Mol Gastroenterol Hepatol Zarour 3 163 2017 10.1016/j.jcmgh.2017.01.006 Colorectal cancer liver metastasis: evolving paradigms and future directions 

   상세보기

5. Nat Med Batlle 23 1124 2017 10.1038/nm.4409 Cancer stem cells revisited 

   상세보기

6. Gastroenterology Anderson 139 718 2010 10.1053/j.gastro.2010.07.012 Caught in the Akt: regulation of Wnt signaling in the intestine 

   상세보기

7. Am J Physiol Cell Physiol Novellasdemunt 309 C511 2015 10.1152/ajpcell.00117.2015 Targeting Wnt signaling in colorectal cancer. A review in the theme: cell signaling: proteins, pathways and mechanisms 

   상세보기

8. J Clin Invest Westphalen 124 1283 2014 10.1172/JCI73434 Long-lived intestinal tuft cells serve as colon cancer-initiating cells 

   상세보기

9. Cell Schwitalla 152 25 2013 10.1016/j.cell.2012.12.012 Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties 

   상세보기

10. Nat Cell Biol Vermeulen 12 468 2010 10.1038/ncb2048 Wnt activity defines colon cancer stem cells and is regulated by the microenvironment 

    상세보기

11. Cancer Res Shenoy 72 5091 2012 10.1158/0008-5472.CAN-12-1806 Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors 

    상세보기

12. Anticancer Res Chikazawa 30 2041 2010 Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells 

    상세보기

13. Genes Dis Mohammed 3 11 2016 10.1016/j.gendis.2015.12.004 Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance 

    상세보기

14. Cancer Sci Uchida 101 1731 2010 10.1111/j.1349-7006.2010.01571.x Overexpression of leucine rich repeat containing G protein coupled receptor 5 in colorectal cancer 

    상세보기

15. Mol Cancer Res Emons 15 1481 2017 10.1158/1541-7786.MCR-17-0205 Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt/β-catenin signaling 

    상세보기

16. Nat Rev Drug Discov Kahn 13 513 2014 10.1038/nrd4233 Can we safely target the WNT pathway? 

    상세보기

17. Stem Cells Int Koury 2017 2925869 2017 10.1155/2017/2925869 Targeting signaling pathways in cancer stem cells for cancer treatment 

    상세보기

18. Cancers (Basel) de Sousa E Melo 8 60 2016 10.3390/cancers8070060 Wnt signaling in cancer stem cell biology 

    상세보기

19. Biochemistry Chen 48 10267 2009 10.1021/bi9009677 The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling 

    상세보기

20. Cancer Res Osada 71 4172 2011 10.1158/0008-5472.CAN-10-3978 Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations 

    상세보기

21. J Natl Cancer Inst Sack 103 1018 2011 10.1093/jnci/djr190 Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer 

    상세보기

22. PLoS One Lu 6 e29290 2011 10.1371/journal.pone.0029290 Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway 

    상세보기

23. Mol Cancer Ther Londoño-Joshi 13 800 2014 10.1158/1535-7163.MCT-13-0555 Effect of niclosamide on basal-like breast cancers 

    상세보기

24. Clin Cancer Res Wieland 19 4124 2013 10.1158/1078-0432.CCR-12-2895 Anticancer effects of niclosamide in human glioblastoma 

    상세보기

25. Cancer Lett Li 349 8 2014 10.1016/j.canlet.2014.04.003 Multi-targeted therapy of cancer by niclosamide: a new application for an old drug 

    상세보기

26. PLoS One Wang 8 e74538 2013 10.1371/journal.pone.0074538 Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells 

    상세보기

27. Theranostics Zhou 7 1447 2017 10.7150/thno.17451 The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo 

    상세보기

28. Oncotarget Arend 7 86803 2016 10.18632/oncotarget.13466 Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer 

    상세보기

29. Cancer Res Jang 75 1691 2015 10.1158/0008-5472.CAN-14-2041 Wnt/β-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells 

    상세보기

30. Sci Rep O’Connell 5 14983 2015 10.1038/srep14983 Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications 

    상세보기

31. UICC manual of clinical oncology O'Sullivan 788-90 

32. J Histochem Cytochem Goodpaster 56 347 2008 10.1369/jhc.7A7287.2007 An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue 

    상세보기

33. Oncotarget Kim 7 20395 2016 10.18632/oncotarget.7954 CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment 

    상세보기

34. Sci Rep Jang 5 12465 2015 10.1038/srep12465 Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype 

    상세보기

35. Dis Markers Wang 35 395 2013 10.1155/2013/983981 Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients 

    상세보기

36. Mol Brain Res Engels 120 103 2004 10.1016/j.molbrainres.2003.10.006 Functional differences between two DCLK splice variants 

    상세보기

37. J Hum Genet Omori 43 169 1998 10.1007/s100380050063 Expression and chromosomal localization of KIAA0369, a putative kinase structurally related to Doublecortin 

    상세보기

38. Biochemistry Shang 42 2185 2003 10.1021/bi026913i Catalytic and regulatory domains of doublecortin kinase-1 

    상세보기

39. Nat Genet Nakanishi 45 98 2013 10.1038/ng.2481 Dclk1 distinguishes between tumor and normal stem cells in the intestine 

    상세보기

40. Sci Rep Tharmalingam 8 3701 2018 10.1038/s41598-018-22037-x Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori 

    상세보기

41. Chembiochem Barini 19 425 2018 10.1002/cbic.201700500 The anthelmintic drug niclosamide and its analogues activate the Parkinson's disease associated protein kinase PINK1 

    상세보기

42. Antimicrob Agents Chemother Wu 48 2693 2004 10.1128/AAC.48.7.2693-2696.2004 Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide 

    상세보기

43. Clin Transl Med Abdullah 2 3 2013 10.1186/2001-1326-2-3 Mechanisms of chemoresistance in cancer stem cells 

    상세보기

44. Mol Cancer Chandrakesan 16 30 2017 10.1186/s12943-017-0594-y Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells 

    상세보기

45. J Carcinog Mutagen Chandrakesan 7:257 2016 Regulatory roles of Dclk1 in epithelial mesenchymal transition and cancer stem cells 

46. Int J Cancer Liu 142 2068 2018 10.1002/ijc.31232 DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer 

    상세보기

47. In Vivo Takiyama 32 365 2018 DCLK1 expression in colorectal polyps increases with the severity of dysplasia 

48. Mol Cancer Res Sarkar 15 1678 2017 10.1158/1541-7786.MCR-17-0287 FOXD3 regulates CSC marker, DCLK1-S, and invasive potential: prognostic implications in colon cancer 

    상세보기

49. Lab Invest Sarkar 97 1245 2017 10.1038/labinvest.2017.40 A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy 

    상세보기

50. J Natl Cancer Inst Thun 94 252 2002 10.1093/jnci/94.4.252 Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues 

    상세보기